Adiponectin, Leptin, and Chemerin in Elderly Patients with Type 2 Diabetes Mellitus: A Close Linkage with Obesity and Length of the Disease
Table 2
Body mass index, biochemical, and adipokine data according to age of T2DM patients.
T2DM middle-aged group ()
T2DM older group ()
value
Gender (F/M)
19/20
18/16
0.721
Age (years)
56 ± 7
73 ± 5
<0.001
Length of disease (years)
8 ± 6
11 ± 8
0.047
Body mass index (kg/m2)
26 ± 4
28 ± 4
0.135
Glucose (mg/dL)
130 106–172
126 100–162
0.812
Glycated hemoglobin (%)
6.7 6.1–8.0
7.1 6.5–8.0
0.803
Total cholesterol (mg/dL)
195 ± 56
197 ± 47
0.876
HDL cholesterol (mg/dL)
40 ± 10
40 ± 11
0.970
Triglycerides (mg/dL)
99 77–152
129 92–180
0.157
Adiponectin (μg/mL)
7.0 5.2–10.1
5.4 3.7–7.6
0.012*
Leptin (ng/mL)
12.4 3.4–21.6
37.9 17.7–57.8
<0.001
Male
4.8 2.0–7.5a
18.4 9.4–19.8a
<0.001
Female
21.6 17.0–48.0
55.9 42.4–63.0
0.001*
Chemerin (ng/mL)
145 107–180
188 169–219
<0.001
F: female; HDL: high-density lipoprotein; M: male.
*Loss of significance after statistical adjustment for length of disease.
a: male versus female <0.001.
